Celyad Oncology Overview

  • Founded
  • 2004
Founded
  • Status
  • Public
  • Employees
  • 92
Employees
  • Stock Symbol
  • CYAD
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $4.34
  • (As of Friday Closing)

Celyad Oncology General Information

Description

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Contact Information

Website
celyad.com
Formerly Known As
Cardio3 BioSciences
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
BRU
Primary Office
  • Axis Business Park
  • Rue Edouard Belin 2
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 010 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Celyad Oncology Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.34 $4.38 $4.01 - $10.27 $67.3M 15.5M 30.1K -$1.26

Celyad Oncology Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 69,645 87,670 118,822 155,031
Revenue 0 6 7 3,676
EBITDA (17,242) (29,777) (43,727)
Net Income (18,431) (19,611) (32,052) (44,166)
Total Assets 74,601 81,281 100,632 107,869
Total Debt 3,667 4,475 4,887 1,883
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Celyad Oncology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Celyad Oncology‘s full profile, request access.

Request a free trial

Celyad Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to
Biotechnology
Mont-Saint-Guibert, Belgium
92 As of 2020
00000
000000000 00000

00000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000000000000
Planegg, Germany
00 As of 0000
00000
000000000 00000

000000 0

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celyad Oncology Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediGene Formerly VC-backed Planegg, Germany 00 00000 000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 Formerly VC-backed Paris, France 000 00000 00000000 00000
You’re viewing 5 of 26 competitors. Get the full list »

Celyad Oncology Executive Team (15)

Name Title Board Seat Contact Info
Filippo Petti Chief Executive Officer & Chief Financial Officer, Finance
Philippe Dechamps Secretary, Administration & Chief Legal Officer, Legal
David Gilham Chief Scientific Officer
Stephen Rubino Ph.D Executive
Frédéric Lehmann MD Vice President, Clinical Development & Medical Affairs
You’re viewing 5 of 15 executive team members. Get the full list »

Celyad Oncology Board Members (16)

Name Representing Role Since
00000 00000 Self Non-Executive Director 000 0000
0000000 0000000000 Self Board Member 000 0000
00000 0000000 Celyad Oncology Board Member 000 0000
00000 0000000 00.0 Self Board Member 000 0000
000000 0000000 Celyad Oncology Chairman & Founder 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Celyad Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celyad Oncology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Celyad Oncology‘s full profile, request access.

Request a free trial

Celyad Oncology Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000 (0 06-Jan-2015 000000000000000000 00000 Biotechnology 000000000 00000 00
CorQuest Medical 05-Nov-2014 Merger/Acquisition Surgical Devices 000000000 00000 00
To view Celyad Oncology’s complete acquisitions history, request access »